100
Participants
Start Date
September 21, 2020
Primary Completion Date
May 5, 2022
Study Completion Date
May 5, 2022
Hydroxychloroquine + Metabolic cofactor supplementation
Treatment arm will include dietary supplement consisting of serine, L-carnitine tartrate, N-acetylcysteine and nicotinamide riboside + standard therapy (hydroxychloroquine).
Hydroxychloroquine + Sorbitol
Placebo comparator will include sorbitol as placebo + standard therapy (hydroxychloroquine).
University of Health Sciences Istanbul Ümraniye Training and Research Hospital, Istanbul
Collaborators (1)
Istanbul Medipol University Hospital
OTHER
Istanbul Umraniye Training and Research Hospital
UNKNOWN
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
OTHER_GOV
Dr. Lutfi Kirdar Kartal Training and Research Hospital
OTHER_GOV
Bagcilar Training and Research Hospital
OTHER_GOV
Kanuni Sultan Suleyman Training and Research Hospital
OTHER
Alanya Alaaddin Keykubat University Alanya Training and Research Hospital
UNKNOWN
Canakkale 18 Mart University Health Research and Application Hospital
UNKNOWN
Monitor CRO
INDUSTRY
ScandiBio Therapeutics AB
INDUSTRY